151 results
Page 3 of 8
6-K
EX-99.1
hevl9h9
11 May 23
Current report (foreign)
6:07am
6-K
EX-99.1
vopsc
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
aw49oo129d1qgdlx
13 Dec 22
Takeda to Acquire Late-Stage, Potential Best-in-Class, Oral Allosteric TYK2 Inhibitor NDI-034858 From Nimbus Therapeutics
7:00am
6-K
af1e19n
8 Dec 22
Current report (foreign)
6:46am
6-K
EX-99.1
6l6lfrwlpv1c2ht8b
30 Nov 22
Current report (foreign)
6:28am
6-K
3ys7y9 0q
4 Nov 22
Current report (foreign)
6:01am
6-K
nuioilp3d1s
27 Oct 22
Current report (foreign)
6:01am
6-K
EX-99.1
mkc2vpw
27 Oct 22
Current report (foreign)
6:01am
6-K
33djf99rr5vfjq
14 Oct 22
Current report (foreign)
7:36am
6-K
jhyci
4 Oct 22
Current report (foreign)
6:06am
6-K
EX-99.1
cz3 2c7mglarucmu403
23 Aug 22
Current report (foreign)
6:13am
6-K
EX-99.1
sj6f 3wv8
4 Aug 22
Current report (foreign)
6:07am
6-K
jwrw96zfighp
4 Aug 22
Current report (foreign)
6:07am
6-K
EX-99.1
3tjdkt4
28 Jul 22
Current report (foreign)
6:09am
6-K
bqeqsvb9bn jbn
28 Jul 22
Current report (foreign)
6:09am
6-K
clc98iwmuttw1sv
29 Jun 22
Current report (foreign)
6:02am
6-K
z3ztg8x b21t1raz
31 May 22
Current report (foreign)
6:20am
6-K
EX-99.1
7zhybbp2ydjr3dd0
31 May 22
Current report (foreign)
6:14am
6-K
EX-99.1
jn17th 8jpzy9t9ja
31 May 22
Current report (foreign)
6:07am